President Trump said he’s looking for “Democrat agencies” to eliminate as revenge for the ongoing government shutdown. The dispute centers on expiring Affordable Care Act subsidies, which Senate Democrats demand be extended in any funding bill to protect health insurance for millions of people. Trump opposes the subsidies, incorrectly claiming undocumented immigrants exploit them, even though they’re ineligible for ACA coverage. (Story URL)
The Supreme Court began its new term Monday, with a docket covering conversion therapy, voting rights, tariffs, and religious freedom. Justices will also hear arguments on state redistricting, including a Louisiana case accused of using race to redraw congressional maps. That case will test whether such changes violate the Voting Rights Act of 1965. The court’s term runs through June, with emergency cases possible. (Story URL)
Two people were killed and four others seriously injured Thursday in a terror attack outside a Manchester synagogue. The attacker drove into worshippers at the Heaton Park Hebrew Congregation before stabbing victims. Officers shot the suspect, who later died. Police confirmed the victims were members of the local Jewish community. He said a vest worn by the attacker appeared to contain explosives, though no device was found. (Story URL)
PepsiCo is speeding up plans to swap artificial dyes for natural alternatives in its snacks and drinks. About 40% of its U.S. products still use synthetic colors. Tostitos and Lay’s will be the first brands to transition, with naturally dyed chips expected later this year and dips early next year. PepsiCo is testing ingredients such as paprika, turmeric, purple sweet potatoes and carrots to match the bright colors of products like Flamin’ Hot Cheetos. (Story URL)
The FDA has approved a second generic version of the abortion pill mifepristone, sparking criticism from anti-abortion groups and Republican lawmakers. Evita Solutions announced the approval of its lower-cost pill, which is authorized for use through 10 weeks of pregnancy. The approval comes as Trump officials pledged to review the drug’s safety, despite 25 years of FDA findings that mifepristone is safe and effective. (Story URL)
